In the Wake of Malaria’s Rage – Invest in the Future. Defeat Malaria. World Malaria Day 2014
27 April 2014
by admin
(0) Comments
In the Wake of Malaria’s Rage – Invest in the Future. Defeat Malaria. World Malaria Day 2014
Invest in the Future. Defeat Malaria. World Malaria Day 2014
We are not there yet. Malaria still kills an estimated 627 000 people every year, mainly children under 5 years of age in sub-Saharan Africa. In 2013, 97 countries had on-going malaria transmission. Every year, more than 200 million cases occur; most of these cases are never tested or registered. Emerging drug and insecticide resistance threaten to reverse recent gains.If the world is to maintain and accelerate progress against malaria, in line with Millennium Development Goal (MDG) 6, and to ensure attainment of MDGs 4 and 5, more funds are urgently required. As we mark World Malaria Day today, should we not take time to reflect on the 7th Anniversary of a disease that has caused such harm that none of us will ever forget?
Let us come together to remember and turn the spotlights on the efforts made to control Malaria and to pledge ourselves to continue in the fight until Africa is Malaria free!
Together, we can defeat Malaria!
Malaria in the NewsHow governments can help in the fight against vector borne disease By Akudo Anyanwu Ikemba, CEO Friends AfricaAlmost 20% of all infectious diseases are vector-borne – the theme of this year’s World Malaria Day is “Invest in the Future, Defeat Malaria”.These diseases typically rely on mosquitoes, ticks and fleas to be transmitted to humans and they include lesser known conditions such as Rocky Mountain spotted fever, cat scratch disease and sleeping sickness (or trypanosomiasis).
They also include some of the world’s most destructive diseases – like malaria and dengue fever. More
Guest Post
Time to Step Up-Africans must lead the way to defeating malaria! By Ayo Ajayi, Vice President, International Development, PATH
…..our work is far from over. In too many places malaria still kills, taking the heaviest toll among our youngest citizens. Plus there is concern that funding for malaria programs has become stagnant and is perhaps even decreasing globally. We know what happens when malaria funding dries up-we have seen that before. Illness and death from this preventable and curable disease quickly ramps back up and we lose the gains already made. That truly would be a nightmare.
In order to make sustained progress, we need to…more
Development of the Second Global Malaria Action PlanThe Roll Back Malaria Partnership has initiated the process of developing the second Global Malaria Action Plan (GMAP2) for the period 2016-2025. The crafting of the GMAP2 is taking a highly participatory approach involving stakeholders from across the RBM constituencies, including Governments, Bilateral & Multilateral Agencies, Foundations, Research & Academia, Civil Society and the Private Sector.Regional consultations are already underway, whilst key informant interviews and country level consultations are set to commence soon.
The process is being overseen by the GMAP2 Task Force, and closely coordinated with the elaboration of the WHO Global Technical Strategy for Malaria.
The GMAP2 will provide a global framework for action around which partners can coordinate their efforts to control and eliminate malaria.
It is being developed to guide the financing and implementation of the Global Technical Strategy.
Click here to participate in the process of creating the GMAP2 document.
By Akudo Anyanwu Ikemba, CEO Friends AfricaAlmost 20% of all infectious diseases are vector-borne – the theme of this year’s World Malaria Day is “Invest in the Future, Defeat Malaria”.These diseases typically rely on mosquitoes, ticks and fleas to be transmitted to humans and they include lesser known conditions such as Rocky Mountain spotted fever, cat scratch disease and sleeping sickness (or trypanosomiasis).
The crafting of the GMAP2 is taking a highly participatory approach involving stakeholders from across the RBM constituencies, including Governments, Bilateral & Multilateral Agencies, Foundations, Research & Academia, Civil Society and the Private Sector.